Cancers (Mar 2021)

Genomic Signature of Oral Squamous Cell Carcinomas from Non-Smoking Non-Drinking Patients

  • Kendrick Koo,
  • Dmitri Mouradov,
  • Christopher M. Angel,
  • Tim A. Iseli,
  • David Wiesenfeld,
  • Michael J. McCullough,
  • Antony W. Burgess,
  • Oliver M. Sieber

DOI
https://doi.org/10.3390/cancers13051029
Journal volume & issue
Vol. 13, no. 5
p. 1029

Abstract

Read online

Molecular alterations in 176 patients with oral squamous cell carcinomas (OSCC) were evaluated to delineate differences in non-smoking non-drinking (NSND) patients. Somatic mutations and DNA copy number variations (CNVs) in a 68-gene panel and human papilloma virus (HPV) status were interrogated using targeted next-generation sequencing. In the entire cohort, TP53 (60%) and CDKN2A (24%) were most frequently mutated, and the most common CNVs were EGFR amplifications (9%) and deletions of BRCA2 (5%) and CDKN2A (4%). Significant associations were found for TP53 mutation and nodal disease, lymphovascular invasion and extracapsular spread, CDKN2A mutation or deletion with advanced tumour stage, and EGFR amplification with perineural invasion and extracapsular spread. PIK3CA mutation, CDKN2A deletion, and EGFR amplification were associated with worse survival in univariate analyses (p CDKN2A mutations, EGFR amplifications, and BRCA2 deletions (p < 0.05 for all comparisons), with a younger subset showing higher mutation burden. HPV was detected in three OSCC patients and not associated with smoking and drinking habits. NSND OSCC exhibits distinct genomic profiles and further exploration to elucidate the molecular aetiology in these patients is warranted.

Keywords